Sales of Novartis products, which include the hypertension drug Diovan and anticancer drug Glivec — known as Gleevec in the United States, rose 28 percent ...
Wall Street Journal - Jeanne Whalen - Jan 26, 2010
... off-label marketing" and payments to health-care providers involving five other Novartis drugs: Diovan, Exforge, Sandostatin, Tekturna and Zelnorm. ...
Wall Street Journal - Jeanne Whalen - Jan 28, 2010
... and payments to health-care providers involving five other Novartis drugs, the company said: Diovan, Exforge, Sandostatin, Tekturna and Zelnorm. ...
The drug is on China's National Medical Reimbursement Insurance List, making it eligible for insurance reimbursement. Sinobiopharma (OTCBB: SNBP) reported ...
The maker of blood pressure drug Diovan and anticancer drug Gleevec offered a positive outlook for 2010, predicting mid-to-high single digit growth in its ...